This is awarded to the best Patey Prize Paper awarded at the SARS Annual Meeting.
2017 – Royal College of Surgeons In Ireland
MECHANISMS UNDERLYING HUMAN VENOUS VALVE DISEASE CAUSED BY MUTATIONS IN FOXC2 AND CONNEXIN47
OTA Lyons (1), P Saha (1), C Seet (1), A Kuchta (2), A Arnold (2), S Grover (3), V Rashbrook (1), A Sabine (4), G Vizcay-Barrena (5), A Patel (1), F Ludwinski (1), S Padayachee (2), T Kume (6), B Kwak (7), G Brice (8), S Mansour (8), P Ostergaard (9), P Mortimer (9), S Jeffery (9), N Brown (10), T Makinen (11), T Petrova (4), B Modarai (1), A Smith (1)
(1) Academic Department of Vascular Surgery, Cardiovascular Division, BHF Centre of Research Excellence, King’s College London, St Thomas’ Hospital, UK (2) Department of Ultrasonic Angiology, Guys & St Thomas’ NHS Foundation Trust, UK (3) Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, USA (4) Department of Fundamental Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Epalinges, Switzerland (5) Center for Ultrastructural Imaging, King’s College London, UK (6) Feinberg Cardiovascular Research Institute, Northwestern University School of Medicine, USA (7) Department of Pathology and Immunology, University of Geneva, Switzerland (8) SW Thames Regional Genetics Service, St George’s Hospital, United Kingdom (9) Cardiovascular and Cell Sciences Institute, St George’s University of London, UK (10) Institute of Medical & Biomedical Education, St George’s University of London, United Kingdom (11) Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
2016 – Royal College of Surgeons of England
THE DEVELOPMENT OF A NANOCOMPOSITE AURICULAR IMPLANT WITH ADIPOSE STEM CELLS FOR CLINICAL TRANSLATION.
M Griffin, D Kalaskar, A Seifalian A, PE Butler. UCL Centre for Nanotechnology & Regenerative Medicine
2015 – Durham University
ONCOLYTIC JX-594-BASED VACCINIA VIRUS TREATMENT OF COLORECTAL CANCER METASTASES; DIRECT LYSIS AND ACTIVATION OF ANTI-TUMOUR IMMUNITY
RV Dave (1,2), A Peckham-Cooper (1,2), F Errington-Mais (1), E West (1), P Selby (1), GJ Toogood (2), AA Melcher (1). (1) Department of Hepatobiliary and Transplant Surgery, St James’s University Hospital (2) Targeted and Biological Therapies group, Leeds Institute of Cancer & Pathology, Leeds University.
2014 – Robinson College, University of Cambridge
HETEROGENEITY IN INDIRECT PATHWAY CD4 T CELL ALLORESPONSES
JM Ali, MC Negus, EM Bolton, K Saeb Parsy, JA Bradley, GJ Pettigrew. Department of Surgery, University of Cambridge.
2013 – Royal Society of Medicine, London
Availability of T Cell help determines alloantibody levels and graft outcome in a murine model of antibody-mediated rejection.
M Chhabra, CJ Callaghan, S Rehakova, MC Negus, EM Bolton, JA Bradley, GJ Pettigrew. Department of Surgery, University of Cambridge.
2012 – University of Nottingham
Regulatory B Cells induce long-term allograft survival in a mouse model of chronic rejection
M Mallik, CJ Callaghan, M Negus, JA Bradley, GJ Pettigrew, University Department of Surgery, Addenbrooke’s Hospital, Cambridge Biomedical Research Centre, Cambridge.
2011 – RCSI Dublin
The contribution of the RNA-binding protein RNPC1 to P21-mediated cell cycle arrest and radiation sensitivity in oesophageal cancer
Gijsbert Jan Hötte (1,2), Stephen G. Maher (1), John V. Reynolds (1), (1)Department of Surgery, Institute of Molecular Medicine, Trinity Centre for Health Sciences, Trinity College Dublin and (2) Department of Surgery, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands.
2010 – London
Heme arginate ameliorates hepatic ischaemia reperfusion injury through modification of macrophage
Stephen McNally, MRC Centre for Inflammation Research, University of Edinburgh.
2009 – Bristol
How Does the Gut know it is Lunch Time? The Role of the Proximal Intestine in Regulating Enteric Nutrient Uptake
Adam T. Stearns, Dept of Surgery, Brigham & Women’s Hospital & Harvard Medical School, Boston, United States & Eastern Deanery Higher Surgical Training Rotation.
2008 – Birmingham
Proteomic Analysis Of The Proto-Oncogene C-MYC Unfolds A Mechanism Of Receptor Cross-Talk That Drives Tumour Recurrence.
Ms Dearbhaile Collins, Department of Surgical Research, RCSI & Beaumont Hospital, Dublin, Ireland.
2007 – Cambridge
Adenovirus-mediated vegf gene therapy enhances venous thrombus recanalisation and resolution.
Bijan Modarai, Academic Surgery, St Thomas’ Campus, King’s College, London, UK